What is peritoneal vascular thrombosis, including its risk factors, clinical presentation, diagnostic approach, and management?

Peritoneal Vascular Thrombosis (Mesenteric Venous Thrombosis)

Definition and Clinical Significance

Peritoneal vascular thrombosis, more accurately termed mesenteric venous thrombosis (MVT), is a life-threatening occlusion of the mesenteric and portal venous system that can rapidly progress to bowel ischemia and infarction if not promptly recognized and treated. MVT accounts for 5-15% of acute mesenteric ischemia cases and carries a mortality rate of 20-50% when bowel infarction develops 1.

The condition involves thrombosis of the superior mesenteric vein, portal vein, or their tributaries, leading to venous congestion, bowel edema, increased vascular resistance, and ultimately reduced arterial inflow causing intestinal ischemia 1.

---

Risk Factors

Hypercoagulable States (Most Common)

• Inherited thrombophilias: Factor V Leiden, prothrombin G20210A mutation, protein C deficiency, protein S deficiency, antithrombin deficiency, and antiphospholipid syndrome 1, 2
• Myeloproliferative neoplasms: The most common acquired thrombophilic cause, with JAK2V617F mutations detected in 20-40% of splanchnic vein thrombosis patients 2
• Paroxysmal nocturnal hemoglobinuria: Demonstrates high propensity for splanchnic thrombosis 2

Local Abdominal Factors

• Portal hypertension and cirrhosis: The dominant risk factor in cirrhotic patients, with prevalence ranging from 2.1% to 23.3% in transplant candidates 1, 2
• Pancreatitis and intra-abdominal infections: Inflammatory processes alter blood flow and promote thrombosis 1, 2
• Recent abdominal surgery: Particularly splenectomy increases risk 2
• Hepatocellular carcinoma: Present in 20-30% of HCC patients at diagnosis 2
• Inflammatory bowel disease: Contributes to local inflammatory milieu 1

Systemic and Medication-Related Factors

• Oral contraceptives and estrogen therapy: Linked to splanchnic vein thrombosis 1, 2
• Malignancies: Especially hepatobiliary and pancreatic cancers 2
• Sepsis and trauma: Alter blood flow dynamics 1

Approximately 20% of cases remain idiopathic despite thorough evaluation 1.

---

Clinical Presentation

Cardinal Symptom

Severe abdominal pain out of proportion to physical examination findings is the hallmark presentation and should be assumed to be acute mesenteric ischemia until proven otherwise 1.

Common Presenting Features

• Abdominal pain: Present in 84-95% of patients, often diffuse and progressive 1, 3
• Nausea and vomiting: Occurs in 32-44% of cases 1, 3
• Diarrhea: Reported in 35-42% of patients 1, 3
• Gastrointestinal bleeding: Occurs in 10-16%, including blood per rectum 1

Advanced Presentation (Indicates Bowel Necrosis)

• Peritoneal signs: Suggest irreversible intestinal ischemia with bowel necrosis 1
• Septic shock: May occur with delayed diagnosis 1
• Persistent severe pain despite anticoagulation: Concerning for venous mesenteric infarction 1
• Organ failure: Shock, renal failure, metabolic acidosis, elevated arterial lactate 1
• Massive ascites and rectal bleeding: Suggestive of infarction 1

The clinical presentation is highly variable and often mimics more common causes of abdominal pain, making diagnosis challenging 4, 3.

---

Diagnostic Approach

Initial Laboratory Studies

• Leukocytosis: Abnormally elevated in >90% of patients 1
• Metabolic acidosis with elevated lactate: Present in 88% of cases, though not specific for early disease 1
• D-dimer: May assist in diagnosis but lacks sufficient accuracy to rule out disease 1
• Baseline coagulation studies: PT, aPTT, liver and kidney function tests 1

No laboratory study is sufficiently accurate to definitively identify or exclude ischemic or necrotic bowel 1.

Imaging Strategy

First-Line: Contrast-Enhanced CT Scan (Portal Phase)

Portal phase CT scan is the primary diagnostic test of choice, showing absence of visible lumen corresponding to portal vein clot and providing critical information about thrombus extent 1.

• Optimal timing: Portal phase acquisition is mandatory; late arterial phase images are inadequate and may cause false positives 1
• Key findings: Absence of portal vein lumen, thrombus extension to mesenteric veins, bowel wall abnormalities (thickening, abnormal enhancement), mesenteric stranding, pneumatosis, portal venous gas 1
• Prognostic indicators: Distal thrombosis (second-order superior mesenteric vein radicals), bowel wall abnormalities, large ascites, and pneumatosis predict need for intestinal resection 1
• Diagnostic accuracy: CT diagnosed MVT in 90% of patients overall and 100% of those presenting with vague abdominal pain or diarrhea 3

Doppler Ultrasound

• Limited sensitivity: May detect absence of portal flow and hyperechoic thrombus, but operator-dependent and less sensitive than CT 1
• Role: Usually the first imaging performed but requires confirmation with CT or MR 1

Plain Radiography

• Limited value: Only becomes positive when bowel infarction occurs, showing signs of intestinal perforation or free intraperitoneal air 1
• Cannot exclude disease: A negative radiograph does not exclude mesenteric ischemia 1

Angiography

• Poor sensitivity: Demonstrated MVT in only 55.5% of patients in one series 3
• Limited role: Rarely used for diagnosis but may be employed for therapeutic intervention 1

Chronicity Assessment

• Recent thrombosis: Defined pragmatically as occurring within the last 6 months, based on data showing thrombi not recanalized within 6 months are unlikely to respond to anticoagulation 1
• Imaging clues: Spontaneous hyperdense clot on non-enhanced CT suggests <30 days from symptom onset; absence of portal cavernoma also suggests acute thrombosis, though cavernoma may develop as early as 15-30 days 1

---

Management

Immediate Anticoagulation (Cornerstone of Therapy)

For patients with MVT and evidence of intestinal ischemia, urgent anticoagulation is mandatory to minimize ischemic injury and prevent progression to bowel infarction 1.

Goals of Anticoagulation

1. Prevent extension of thrombosis to mesenteric veins and thereby prevent mesenteric venous infarction 1
2. Achieve portal vein recanalization 1

Evidence for Anticoagulation

• Prevents thrombus extension: Early anticoagulation prevented extension in 100% of patients in a prospective study 1
• Reduces infarction: Only 2/95 cases of limited intestinal infarction occurred despite 60% having initial superior mesenteric vein involvement 1
• Promotes recanalization: Achieved in 39% of portal veins, 80% of splenic veins, and 73% of superior mesenteric veins in anticoagulated patients 1
• Timing matters: Recanalization did not occur beyond 6 months of treatment 1
• Reduces mortality: Historical mortality of 20-50% has declined to 2-20% with anticoagulation 1, 3
• Bleeding risk: Occurs in 9% of patients, with 2% mortality rate not related to bleeding or PVT 1

Anticoagulation Regimen

• Initial therapy: Low molecular weight heparin (LMWH) or unfractionated heparin 3, 5
• Long-term therapy: Warfarin (Coumadin) for at least 3-6 months 3, 5
• Duration: Continue until recanalization or lifelong if underlying permanent pro-coagulant condition exists or thrombosis extends to mesenteric veins 5
• Survival benefit: 79% of survivors in one series were treated with long-term warfarin, with 88% surviving at mean 57.7-month follow-up 3

Multidisciplinary Team Approach

Patients with MVT and intestinal ischemia require management by a multidisciplinary team including gastroenterology/hepatology, interventional radiology, hematology, and surgery 1. If these services are unavailable, transfer to a center with these capabilities should be considered 1.

Surgical Intervention

Indications for Exploratory Laparotomy

• Peritoneal signs: Indicate likely irreversible intestinal ischemia with bowel necrosis 1
• Persistent severe pain despite adequate anticoagulation: Suggests venous mesenteric infarction 1
• Imaging evidence of bowel perforation or necrosis: Pneumatosis, portal venous gas, free air 1

Surgical Procedures

• Bowel resection: Required in 32% of patients in one series 3
• Limited resection with simultaneous thrombolytic infusion: Via operatively placed mesenteric vein catheter has been successful 6, 7
• Peritoneal washout: For perforation and peritonitis 4

Predictors of Need for Resection

• Diabetes: The only factor independently associated with intestinal resection in one study 1
• Imaging findings: Distal thrombosis, bowel wall abnormalities, large ascites, pneumatosis 1

Advanced Interventional Therapies

Catheter-Directed Thrombolysis

• Technique: Recombinant tissue-plasminogen activator (rt-PA) infusion via operatively placed catheter into portal and superior mesenteric vein 6, 7
• Success: Complete recanalization achieved within 36 hours in reported cases 7
• Advantage: Direct pharmacologic thrombolysis with decreased infusion required and possibility for concurrent dilation or thrombectomy 7
• Consideration: Should be considered if no clinical improvement with anticoagulation alone 1

Transhepatic or Transjugular Routes

• Alternative access: Thrombolysis through superior mesenteric artery, jugular vein, or portal vein via transhepatic route may be successful in selected patients 6

Supportive Care

• Fluid resuscitation: For hypovolemia and shock 1
• Blood transfusions: For significant blood loss 1
• Total parenteral nutrition: During recovery from bowel resection 4
• Prolonged antibiotics: For peritonitis and sepsis 4

---

Prognosis and Outcomes

Mortality

• Overall 30-day mortality: 23% in one series 3
• With anticoagulation: Mortality reduced to 2-20% from historical rates of 20-50% 1, 3
• Without anticoagulation: Four of nine non-anticoagulated patients died in one series 3

Recanalization

• Spontaneous recanalization: Exceptional in patients not receiving anticoagulation 1
• With anticoagulation: Achieved in 39-80% depending on vessel involved 1

Long-Term Complications

• Short bowel syndrome: Risk with extensive resection 1
• Portal hypertension: May develop with chronic thrombosis 5
• Recurrent thrombosis: Risk remains if underlying hypercoagulable state persists 5

---

Critical Pitfalls to Avoid

• Delayed diagnosis: High index of suspicion is essential; pain out of proportion to exam findings should prompt immediate imaging 1
• Relying on plain radiography: Only positive when bowel infarction has occurred 1
• Inadequate CT timing: Late arterial phase images may cause false positives; portal phase is mandatory 1
• Withholding anticoagulation: Early anticoagulation is critical even before definitive diagnosis if clinical suspicion is high 1, 3
• Failure to screen for hypercoagulable states: Underlying thrombophilia is present in many cases and requires specific therapy 1, 3
• Inadequate treatment duration: Anticoagulation should continue for at least 3-6 months or until recanalization 5